Related Experiment Video

Updated: Oct 8, 2026

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
06:47

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment

Published on: September 27, 2017

Exposure to pets and atopy-related diseases in the first 4 years of life

P Nafstad1, P Magnus, P I Gaarder

  • 1Department of Population Health Sciences, National Institute of Public Health, Oslo, Norway.

Allergy
|April 4, 2001
PubMed

Insights

Early-life pet exposure may reduce the risk of atopy-related diseases in children. This study investigated the association between pet ownership and conditions like asthma and eczema in Norwegian children.

Area of Science:

  • Pediatrics
  • Environmental Health
  • Epidemiology

Background:

  • The relationship between early-life pet exposure and atopy-related diseases remains unclear.
  • Atopy-related diseases, such as asthma and eczema, are common in childhood.

Purpose of the Study:

  • To investigate the association between early-life pet exposure and the risk of developing atopy-related diseases in children.
  • To analyze data from a Norwegian birth cohort to understand this relationship.

Main Methods:

  • A population-based cohort of 2531 Norwegian children was followed from birth to age 4.
  • Data on pet exposure, confounders, and atopy-related diseases were collected via questionnaires.

Main Results:

  • Early-life pet exposure showed a reduced odds ratio for allergic rhinitis (0.6) and atopic eczema (0.7) at specific ages.
  • Associations for bronchial obstruction and asthma were not statistically significant, but trends suggested potential risk reduction.

Conclusions:

  • Early-life pet exposure may be associated with a reduced risk of developing atopy-related diseases in childhood.
  • Lifestyle factors or selection bias related to pet ownership could influence these findings.
Abstract

More Related Videos

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Allergic Reactions02:06

Allergic Reactions

Overview
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...